Cover Image
市場調查報告書

Q Chip Ltd.的產品平台分析

Q Chip Ltd. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 312703
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Q Chip Ltd.的產品平台分析 Q Chip Ltd. - Product Pipeline Review - 2014
出版日期: 2014年09月10日 內容資訊: 英文 21 Pages
簡介

Q Chip Ltd.是總公司位於英國的新藥開發公司,正在開發基於生物封裝的生命科學產品及藥物。

本報告提供Q Chip Ltd.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Q Chip Ltd.的基本資料

  • Q Chip Ltd.概要
  • 主要資訊
  • 企業資料

Q Chip Ltd.:R&D概要

  • 主要的治療範圍

Q Chip Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Q Chip Ltd.:開發中產品概況

  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Q Chip Ltd.:藥物簡介

  • leuprolide acetate SR
  • octreotide SR
  • goserelin SR
  • Proteins/MAbs for Undisclosed Indication
  • Q-Diabetes

Q Chip Ltd.:開發平台分析

  • 標的別
  • 各分子類型
  • 各作用機制

Q Chip Ltd.:總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

目錄
Product Code: GMDHC06411CDB

Summary

Global Markets Direct's, 'Q Chip Ltd. - Product Pipeline Review - 2014', provides an overview of the Q Chip Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Q Chip Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Q Chip Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Q Chip Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Q Chip Ltd.'s pipeline products

Reasons to buy

  • Evaluate Q Chip Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Q Chip Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Q Chip Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Q Chip Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Q Chip Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Q Chip Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Q Chip Ltd. Snapshot
    • Q Chip Ltd. Overview
    • Key Information
    • Key Facts
  • Q Chip Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Q Chip Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Q Chip Ltd. - Pipeline Products Glance
    • Q Chip Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Q Chip Ltd. - Drug Profiles
    • leuprolide acetate SR
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • octreotide SR
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • goserelin SR
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Proteins/MAbs for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Q-Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Q Chip Ltd. - Pipeline Analysis
    • Q Chip Ltd. - Pipeline Products by Target
    • Q Chip Ltd. - Pipeline Products by Molecule Type
    • Q Chip Ltd. - Pipeline Products by Mechanism of Action
  • Q Chip Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Q Chip Ltd., Key Information
  • Q Chip Ltd., Key Facts
  • Q Chip Ltd. - Pipeline by Indication, 2014
  • Q Chip Ltd. - Pipeline by Stage of Development, 2014
  • Q Chip Ltd. - Monotherapy Products in Pipeline, 2014
  • Q Chip Ltd. - Preclinical, 2014
  • Q Chip Ltd. - Discovery, 2014
  • Q Chip Ltd. - Pipeline by Target, 2014
  • Q Chip Ltd. - Pipeline by Molecule Type, 2014
  • Q Chip Ltd. - Pipeline Products by Mechanism of Action, 2014
  • Q Chip Ltd., Subsidiaries

List of Figures

  • Q Chip Ltd. - Pipeline by Top 10 Indication, 2014
  • Q Chip Ltd. - Pipeline by Stage of Development, 2014
  • Q Chip Ltd. - Monotherapy Products in Pipeline, 2014
  • Q Chip Ltd. - Pipeline by Top 10 Target, 2014
  • Q Chip Ltd. - Pipeline by Top 10 Molecule Type, 2014
  • Q Chip Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top